Acorn Capital Advisors, Llc

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$351.8M
Q ending 2026-03-31
Prior quarter
$295.1M
Q ending 2025-12-31
Change
+19.2% QoQ · +134.6% YoY
Positions
22
reported holdings

Largest positions

All 22 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Terns Pharmaceuticals Inc430Shares$92.1M1.7M
Cg Oncology IncCGONShares$76.6M1.1M
Urogen Pharma LtdShares$30.1M1.7M
Puma Biotechnology IncPBYIShares$26.4M4.1M
Trevi Therapeutics IncTRVIShares$25.6M2.1M
Candel Therapeutics IncCADLShares$17.2M3.5M
Bicara TherapeuticsBCAXShares$12.8M643K
Onkure Therapeutics IncOKURShares$11.8M2.8M
Jade Biosceinces IncJBIOShares$11.1M787K
Protara Therapeutics IncTARAShares$9.1M1.8M
Verastem IncVSTMShares$7.8M1.5M
Helus Pharma Inc.HELPShares$7.4M1.5M
Leonabio, Inc.LONAShares$6.5M635K
Aura Biosciences IncAURAShares$4.0M596K
Whitehawk Therapeutics IncWHWKShares$3.9M1.1M
Cardif Oncology IncCRDFShares$2.9M1.8M
Q32 Bio Inc.QTTBShares$2.0M315K
Karyopharm Therapeutics IncKPTIShares$1.6M288K
Jasper TherapeuticsJSPRShares$1.2M1.4M
X4 Pharmaceuticals IncASNSUSDShares$967K234K
Bioatla IncBCABGBPShares$865K5.4M
Vyne Therapeutics IncVYNEShares$8551K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.